Global Blood Therapeutics, Inc. (GBT) (Nasdaq: GBT) announced that the methodology used to develop the Patient Reported Outcome (PRO) tool ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE